Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Azatadine maleate+pseudoephedrine sulfate 1mg/120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
|
Loratadine+pseudoephedrine sulfate 5mg/120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
|
Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
|
Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
|
Product containing azatadine maleate and pseudoephedrine sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
|
Product containing loratadine and pseudoephedrine sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
|
Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
1 |
Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
1 |
Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
1 |
Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
2 |
Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
2 |
Loratadine+pseudoephedrine sulfate 5mg/120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
|
Product containing precisely dexbrompheniramine maleate 6 milligram and pseudoephedrine sulfate 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
2 |
Product containing precisely dexbrompheniramine maleate 6 milligram and pseudoephedrine sulfate 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
2 |
Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
1 |
Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely dexbrompheniramine maleate 6 milligram and pseudoephedrine sulfate 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely dexbrompheniramine maleate 6 milligram and pseudoephedrine sulfate 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pseudoephedrine sulfate |
Inferred relationship |
Some |
1 |